海洋衍生药品市场(主要地区、市场参与者、规模和份额)- 2031 年预测

  • Report Code : TIPRE00023145
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

预计 2024 年至 2031 年期间海洋药物市场复合年增长率为 8.2%,市场规模将从 2024 年的 XX 百万美元扩大到 2031 年的 XX 百万美元。

报告按类型(苯酚、类固醇、醚、肽、其他)细分。报告进一步根据来源(藻类、无脊椎动物、微生物)进行分析。报告进一步根据给药方式(抗菌、抗肿瘤、抗心血管、抗病毒、抗炎、其他)进行细分。此外,它还根据最终用户(医院和诊所、药房、其他)进行细分。全球分析进一步细分为区域和主要国家。报告以美元为单位提供了上述分析和细分的价值。

报告目的

The Insight Partners 撰写的《海洋药物市场》报告旨在描述当前形势和未来增长、主要驱动因素、挑战和机遇。这将为各种业务利益相关者提供见解,例如:

  • 技术提供商/制造商:了解不断变化的市场动态并了解潜在的增长机会,从而能够做出明智的战略决策。
  • 投资者:对市场增长率、市场财务预测以及整个价值链中存在的机会进行全面的趋势分析。
  • 监管机构:监管市场政策和警察活动,旨在最大限度地减少滥用行为,维护投资者的信任和信心,维护市场的完整性和稳定性。

 

海洋药物市场细分

 

类型

  • 苯酚
  • 类固醇
  • 其他

来源

  • 藻类
  • 无脊椎动物
  • 微生物

交付方式

  • 抗菌
  • 抗肿瘤
  • 抗心血管
  • 抗病毒物质
  • 消炎(药
  • 其他的

最终用户

  • 医院和诊所
  • 药店
  • 其他的

 

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

海洋药物市场:战略洞察

Marine-derived Drugs Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

 

海洋药物市场增长动力

  • 慢性病患病率不断上升:癌症、心血管和神经系统疾病等慢性病患者人数不断增加。对新型有效疗法的迫切需求是海洋药物市场发展的主要推动力。
  • 海洋生物技术的进展:海洋生物学、化学、药理学等相关领域的进步,进一步增强了上述药物的更全面的筛选、提取和开发过程。
  • 对天然和环境友好型替代品的需求不断增长:消费者和医疗保健提供者更加期待天然、环境友好的治疗方法,从而激发了人们对海洋衍生药物作为可持续发现新药物来源的兴趣。

海洋药物市场未来趋势

  • 扩大海洋衍生药物开发渠道:除了抗癌、抗炎等传统药物外,在治疗疼痛相关问题、神经系统疾病和传染病方面也出现了更新的应用开发。
  • 合作研究与开发:制药、学术和研究导向方之间越来越多地结成联盟,共同努力进行新产品的发现和开发。
  • 提取和纯化技术的进步:从海洋生物中提取、分离和纯化生物活性化合物的技术进步大大提高了海洋药物生产的效率和可扩展性。

海洋药物市场机遇

  • 探索较少被探索的海洋栖息地:研究深海和极地等未经研究的海洋生态系统可能会发现具有治疗作用的生物活性化合物的新来源。
  • 合成生物学突破:合成生物学方法的潜在整合,包括代谢工程和定向进化,将提高海洋衍生药物的产量,从而获得更多的商业可行性。
  • 个性化医疗和靶向治疗:具有独特化学结构和作用机制的海洋衍生药物可用于开发个性化和靶向治疗,以满足尚未满足的医疗需求。

 

海洋药物市场区域洞察

Insight Partners 的分析师已详细解释了预测期内影响海洋药物市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的海洋药物市场细分和地理位置。

Marine-derived Drugs Market
  • 获取海洋药物市场的区域具体数据

海洋药物市场报告范围

报告属性细节
2024 年的市场规模XX 百万美元
2031 年市场规模XX 百万美元
全球复合年增长率(2024 - 2031)8.2%
史料2021-2023
预测期2025-2031
涵盖的领域按类型
  • 苯酚
  • 类固醇
  • 其他
按来源
  • 藻类
  • 无脊椎动物
  • 微生物
按交付方式
  • 抗菌
  • 抗肿瘤
  • 抗心血管
  • 抗病毒物质
  • 消炎(药
  • 其他的
按最终用户
  • 医院和诊所
  • 药店
  • 其他的
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 辉瑞公司
  • 雅培
  • 葛兰素史克公司
  • 阿克尔海洋生物公司
  • 法玛玛公司
  • 卫材株式会社
  • 阿克尔海洋生物公司
  • Sea Run 控股公司
  • 阿菲奥斯公司

 

海洋衍生药物市场参与者密度:了解其对业务动态的影响

海洋衍生药物市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在海洋药物市场运营的主要公司有:

  1. 辉瑞公司
  2. 雅培
  3. 葛兰素史克公司
  4. 阿克尔海洋生物公司
  5. 法玛玛公司

免责声明上面列出的公司没有按照任何特定顺序排列。


Marine-derived Drugs Market

 

  • 了解海洋衍生药物市场的主要参与者概况

 

 

主要卖点

 

  • 全面覆盖:报告全面涵盖了海洋衍生药物市场的产品、服务、类型和最终用户的分析,提供了整体概况。
  • 专家分析:报告基于对行业专家和分析师的深入了解而编写。
  • 最新信息:该报告涵盖了最新信息和数据趋势,确保了其与业务的相关性。
  • 定制选项:此报告可以定制以满足特定客户要求并恰当地适应业务策略。

因此,海洋药物市场研究报告有助于引领解读和了解行业情景和增长前景。尽管可能存在一些合理的担忧,但本报告的总体优势往往大于劣势。

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What factors are driving the marine-derived drugs market growth?

The major factors driving the marine-derived drugs market are:

1. Marine Biotechnology Progressions.

2. Rising Demand for Natural and Environment-Friendly Alternatives.

Which region dominated the marine-derived drugs market in 2023?

North America region dominated the marine-derived drugs market in 2023.

Which region accounted for the higesht CAGR in the marine-derived drugs market in 2023?

Asia Pacific region accounted for the highest CAGR in the marine-derived drugs market.

What are the key benefits of the marine-derived drugs market report?

The report provides an extensive qualitative and quantitative analysis of the current trends and future estimations of the global marine-derived drugs market from 2021 to 2031, and it also determines the prevailing opportunities.

Which are some of the major players operating in the market?

Pfizer Inc., Abbott, and GlaxoSmithKline are some of the major players operating in the market.

What is the expected CAGR of the Marine-derived Drugs Market?

The Marine-derived Drugs Market is estimated to witness a CAGR of 8.2% from 2023 to 2031

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. Pfizer, Inc.
2. Abbott
3. GlaxoSmithKline PLC
4. Aker BioMarine AS
5. Pharma Mar S.A
6. Eisai Co., Ltd.
7. Aker BioMarine AS
8. Sea Run Holdings, Inc.
9. Aphios Corporation
10. Pharma Marine USA, LLC
11. Perrigo
12. Bayer AG
13. Takeda Pharmaceuticals
14. Sanofi S.A.
15. Seattle Genetics
16. DSM
17. BASF SE
18. Amway
19. Pelagia (EPAX)
20. Croda
21. GNC
22. TerSera Therapeutics
23. Nordic Naturals
24. Carlson Labs

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.